EB

Ela Borenstein

Vice President Venture Capital Incentivized Programs at BDC and Kauffman Fellow

Montreal, Quebec

Investor
VC

Invests in

Locations:

Montreal

  • Min Investment:

    $2,000,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $3,500,000.00

Skills

Venture Capital
Regulatory Affairs
Biotechnology
Start-ups
Lifesciences
Due Diligence
Strategy
Technology Transfer
Mergers
Clinical Research
Mergers & Acquisitions
Pharmaceutical Industry
Private Equity
Corporate Development
Business Strategy
Entrepreneurship
Commercialization
Life Sciences

Education

Investments

Milestone Pharmaceuticals

Series B

Total Funding: $290M

Thrasos

Series D

Total Funding: $56M

Alethia BioTherapeutics

Seed

Total Funding: $16M

Cytochroma

Series B

Total Funding: $48M

Gemin X Pharmaceuticals

Series Unknown

Total Funding:

Work Experience

BDC

2007

  • Vice President Venture Capital Incentivized Programs

    2021

  • Program Director

    2016 - 2021

  • Partner, Health Venture Fund

    2007 - 2016

Kauffman Fellows

2012

  • Class 17

    2012

Kiadis Pharma

2006 - 2007

  • COO

    2006 - 2007

Celmed

2003 - 2007

  • VP, Reg Affairs/Product Strategy

    2003 - 2007

Theratechnologies

2000 - 2002

  • VP, Regulatory and Clinical Affairs

    2000 - 2002

Technilab Pharma

1993 - 2000

  • Senior VP, Scientific Affairs

    1993 - 2000

LAB BioResearch (formerly BioResearch)

1988 - 1993

  • Director, Clinical Research

    1988 - 1993

  • Director, Clinical Research

    1988 - 1993

Novopharm

1984 - 1988

  • Regulatory Affairs

    1984 - 1988